Titre (en)
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « Titre (en) » - entrée « factor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
facilitates < factor < factors  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000030 (2020) Gulzhan Trimova ; Kaoru Yamagata ; Shigeru Iwata ; Shintaro Hirata [Japon] ; Tong Zhang ; Fumi Uemura ; Minoru Satoh [Japon] ; Norma Biln ; Shingo Nakayamada ; Walter P. Maksymowych ; Yoshiya TanakaTumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages
000032 (2020) Marc Feldmann [Royaume-Uni] ; Ravinder N. Maini [Royaume-Uni] ; James N. Woody [États-Unis] ; Stephen T. Holgate [Royaume-Uni] ; Gregory Winter [Royaume-Uni] ; Matthew Rowland [Royaume-Uni] ; Duncan Richards [Royaume-Uni] ; Tracy Hussell [Royaume-Uni]Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
000085 (2020) Ran Li ; Kunchi Zhao ; Qing Ruan ; Chunyang Meng ; Fei YinThe transcription factor Foxd3 induces spinal cord ischemia-reperfusion injury by potentiating microRNA-214-dependent inhibition of Kcnk2
000135 (2020) Yixin Ally Wang [États-Unis] ; Misha Rosenbach [États-Unis]Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case
000203 (2020) Jae-A Park [Corée du Sud] ; Min-Young Lee [Corée du Sud] ; Jin Hyun Nam [États-Unis] ; Ju-Young Shin [Corée du Sud] ; Robert Wood [Royaume-Uni] ; Tim Holbrook [Royaume-Uni] ; Sun-Hong Kwon [Corée du Sud]Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South Korea.
000241 (2020) Nick Bansback ; Jeffrey R. Curtis ; Jie Huang ; Zeling He ; Michael Evans ; Tracy Johansson ; Kaleb Michaud ; Gabriela Schmajuk ; Katherine P. LiaoPatterns of Tumor Necrosis Factor Inhibitor (TNFi) Biosimilar Use Across United States Rheumatology Practices
000313 (2020) François Santinon [France] ; Maxime Batignes [France] ; Majda Lyna Mebrek [France] ; Jerôme Biton [France] ; Gaëlle Clavel [France] ; Roxane Hervé [France] ; Delphine Lemeiter [France] ; Magali Breckler [France] ; Florence Busato [France] ; Jorg Tost [France] ; Marianne Ziol [France] ; Marie-Christophe Boissier [France] ; Patrice Decker [France] ; Luca Semerano [France] ; Natacha Bessis [France]Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
000324 (2020) Sae Ochi [Japon] ; Kazuyoshi Saito [Japon] ; Fumitaka Mizoguchi [Japon] ; Shigeaki Kato [Japon] ; Yoshiya Tanaka [Japon]Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study
000370 (2020) Yi-Ming Chen [Taïwan] ; Wei-Ting Hung [Taïwan] ; Wan-Chun Chang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Wen-Hung Chung [Taïwan] ; Joung-Liang Lan [Taïwan] ; Ning-Rong Gung [Taïwan] ; Yun-Shien Lee [Taïwan] ; Der-Yuan Chen [Taïwan] ; Shuen-Iu Hung [Taïwan]Genetic Association and Expression Correlation between Colony-Stimulating Factor 1 Gene Encoding M-CSF and Adult-Onset Still's Disease
000383 (2020) Hai-Jian Tu [République populaire de Chine] ; Cheng-Fei Zhao [République populaire de Chine] ; Zhi-Wei Chen [République populaire de Chine] ; Wei Lin [République populaire de Chine] ; Yu-Cai Jiang [République populaire de Chine]Fibroblast Growth Factor (FGF) Signaling Protects Against Acute Pancreatitis-Induced Damage by Modulating Inflammatory Responses
000405 (2020) Kyosuke Hattori [Japon] ; Yuji Hirano [Japon] ; Yasuhide Kanayama [Japon] ; Yosuke Hattori [Japon] ; Takefumi Kato [Japon] ; Nobunori Takahashi [Japon] ; Naoki Ishiguro [Japon] ; Toshihisa Kojima [Japon]Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors.
000517 (2020) Yael Sharon [États-Unis] ; David S. Chu [États-Unis]Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i -k "factor" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/Title.i  \
                -Sk "factor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    factor
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021